Djamshidian Atbin, Poewe Werner
Medical University Innsbruck, Department of Neurology, Innsbruck, Austria.
Medical University Innsbruck, Department of Neurology, Innsbruck, Austria.
Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S9-S12. doi: 10.1016/j.parkreldis.2016.12.004. Epub 2016 Dec 22.
This article reviews the history of apomorphine and levodopa, which were both discovered in the 1950's and have revolutionized treatment paradigms of Parkinson's disease. Although the discovery of levodopa is a prime example of successful translation of basic neuroscience into clinical routine, the history of apomorphine was based on less solid evidence. Despite this, both drugs are, more than 6 decades after the first clinical experiments, still the two most efficacious medications to treat patients with Parkinson's disease. New and promising delivery strategies for both levodopa and apomorphine are currently under investigation to further improve clinical responses.
本文回顾了阿扑吗啡和左旋多巴的历史,它们均于20世纪50年代被发现,并且彻底改变了帕金森病的治疗模式。尽管左旋多巴的发现是基础神经科学成功转化为临床常规应用的一个典型例子,但阿扑吗啡的历史依据却没那么确凿。尽管如此,在首次临床实验过去60多年后,这两种药物仍然是治疗帕金森病患者最有效的两种药物。目前正在研究左旋多巴和阿扑吗啡新的、有前景的给药策略,以进一步改善临床疗效。